Exciting news! Our latest manuscript has just been accepted for publication. Proud to contribute new insights to the role of FXIII and trauma outcomes and work with a wonderful team. @sholzberg@ajbakermd @jeanniecallum @keyvankarkouti https://t.co/GzXkIYVGHo
Presenting our work on FXIII trajectories in trauma patients in the Late Breakthrough session at #ISTH2023. Grateful for the amazing team that made this possible. @sholzberg, @ajbakermd, @JeannieCallum, @KeyvanKarkouti, @juliandaza01, Dr. Erin Fox and the PROPPR study group.
@sholzberg@MaryCushmanMD Thank you, Dr. Cushman! I loved joining a welcoming and inspiring community with amazing female role models like you, @sholzberg and many others!
Welcome Week Two Participants to Target Trial Emulation. We welcome a diverse group of participants from many different areas around the world. #CAUSALabSummer
Welcome Week Two Participants to Target Trial Emulation. We welcome a diverse group of participants from many different areas around the world. #CAUSALabSummer
Very insightful comments by @RichardLehman1: “The purpose of clinical trials is to produce evidence that can inform shared understanding between patients and clinicians about the benefits, harms, and uncertainties of critical treatment choices”
“How do you live when you realize … that your heart might be a government agent, that your amygdala might be working for Putin, and that the next thought that emerges in your mind might well be the result of some algorithm that knows you better than you know yourself?...”
Harari’s latest book is a reflexion on what our future will look like and the role of AI. A must read book. Tech C.E.O.s Are in Love With Their Principal Doomsayer via @NYTimes https://t.co/6QL951Qb6P
Brilliant talk by @GoffiAlberto about the present and future of lung ultrasound. Adding lung u/s to our clinical gestalt increases the sensitivity of our exam to 97% for dx acute heart failure. #CCCF2018
This advice is on point in the context of our conversation on #sleep in the #icu and thinking beyond pharmacological strategies. Can we bring this to patients? #CCCF2018